Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Peter A. McCullough & Thomas A. Verrill. (2010) Cardiorenal Interaction: Appropriate Treatment of Cardiovascular Risk Factors to Improve Outcomes in Chronic Kidney Disease. Postgraduate Medicine 122:2, pages 25-34.
Read now
Read now
Articles from other publishers (16)
Eiichi Araki, Atsushi Tanaka, Nobuya Inagaki, Hiroshi Ito, Kohjiro Ueki, Toyoaki Murohara, Kenjiro Imai, Masataka Sata, Takehiro Sugiyama, Hideki Ishii, Shunsuke Yamane, Takashi Kadowaki, Issei Komuro & Koichi Node. (2020) Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society. Diabetology International 12:1, pages 1-51.
Crossref
Crossref
Eiichi Araki, Atsushi Tanaka, Nobuya Inagaki, Hiroshi Ito, Kohjiro Ueki, Toyoaki Murohara, Kenjiro Imai, Masataka Sata, Takehiro Sugiyama, Hideki Ishii, Shunsuke Yamane, Takashi Kadowaki, Issei Komuro & Koichi Node. (2020) Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes ― A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society ―. Circulation Journal 85:1, pages 82-125.
Crossref
Crossref
Eiichi Araki, Atsushi Goto, Tatsuya Kondo, Mitsuhiko Noda, Hiroshi Noto, Hideki Origasa, Haruhiko Osawa, Akihiko Taguchi, Yukio Tanizawa, Kazuyuki Tobe & Narihito Yoshioka. (2020) Japanese Clinical Practice Guideline for Diabetes 2019. Journal of Diabetes Investigation 11:4, pages 1020-1076.
Crossref
Crossref
Eiichi Araki, Atsushi Goto, Tatsuya Kondo, Mitsuhiko Noda, Hiroshi Noto, Hideki Origasa, Haruhiko Osawa, Akihiko Taguchi, Yukio Tanizawa, Kazuyuki Tobe & Narihito Yoshioka. (2020) Japanese Clinical Practice Guideline for Diabetes 2019. Diabetology International 11:3, pages 165-223.
Crossref
Crossref
Hermann Toplak, Bernhard Ludvik, Monika Lechleitner, Hans Dieplinger, Bernhard Föger, Bernhard Paulweber, Thomas Weber, Bruno Watschinger, Sabine Horn, Thomas C. Wascher, Heinz Drexel, Marianne Brodmann, Ernst Pilger, Alexander Rosenkranz, Erich Pohanka, Rainer Oberbauer, Otto Traindl, Franz Xaver Roithinger, Bernhard Metzler, Hans-Peter Haring & Stefan Kiechl. (2016) Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complicationsÖsterreichischer Lipidkonsensus. Management von Fettstoffwechselstörungen zur Prävention vaskulärer Komplikationen. Wiener klinische Wochenschrift 128:S2, pages 216-228.
Crossref
Crossref
Karen R. Sando & Michelle Knight. (2015) Nonstatin Therapies for Management of Dyslipidemia: A Review. Clinical Therapeutics 37:10, pages 2153-2179.
Crossref
Crossref
Karina Huynh, Bianca C. Bernardo, Julie R. McMullen & Rebecca H. Ritchie. (2014) Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacology & Therapeutics 142:3, pages 375-415.
Crossref
Crossref
Banu Yilmaz & Fusun Toruner. 2013. Endothelium. Endothelium
229
277
.
Sandeep A. Saha & Rohit R. Arora. (2010) Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus – A pooled meta-analysis of randomized placebo-controlled clinical trials. International Journal of Cardiology 141:2, pages 157-166.
Crossref
Crossref
D. Sander & K. Sander. (2009) Schlaganfall-Primärprävention bei DiabetespatientenPrimary stroke prevention in diabetes patients. Der Diabetologe 5:8, pages 611-619.
Crossref
Crossref
Samuel Abourbih, Kristian B. Filion, Lawrence Joseph, Ernesto L. Schiffrin, Stephane Rinfret, Paul Poirier, Louise Pilote, Jacques Genest & Mark J. Eisenberg. (2009) Effect of Fibrates on Lipid Profiles and Cardiovascular Outcomes: A Systematic Review. The American Journal of Medicine 122:10, pages 962.e1-962.e8.
Crossref
Crossref
Dirk Sander & Mark T. Kearney. (2009) Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. Journal of Neurology 256:10, pages 1603-1619.
Crossref
Crossref
Boris N. Mankovsky. 2010. Diabetes and the Brain. Diabetes and the Brain
183
218
.
G. A. Hitman, H. Colhoun, C. Newman, M. Szarek, D. J. Betteridge, P. N. Durrington, J. Fuller, S. Livingstone & H. A. W. Neil. (2007) Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetic Medicine 24:12, pages 1313-1321.
Crossref
Crossref
Bernard Chappuis, Monika Braun, Christoph Stettler, Sabine Allemann, Peter Diem, Peter J. Lumb, Anthony S. Wierzbicki, Richard James & Emanuel R. Christ. (2007) Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study. Diabetes/Metabolism Research and Reviews 23:5, pages 392-399.
Crossref
Crossref
Gloria Lena Vega, Monohar Vajja, Natalia Palacio, Nilo B. CaterP & Scott M. Grundy. (2006) Combination of fenofibrate plus low-dose nicotinic acid added to statin treatment in type 2 diabetes: An open-label, crossover study. Current Therapeutic Research 67:5, pages 321-333.
Crossref
Crossref